Sharps Technology (STSSW) director granted 20,000 options at $6.41

Brenda Baird Simpson, a director of Sharps Technology Inc. (ticker: STSSW), was granted a non‑derivative option to purchase 20,000 shares on 08/22/2025 at an exercise price of $6.41 per share.

Rhea-AI Filing Summary

Brenda Baird Simpson, a director of Sharps Technology Inc. (ticker: STSSW), was granted a non‑derivative option to purchase 20,000 shares on 08/22/2025 at an exercise price of $6.41 per share. The option was granted under the company’s 2025 Equity Incentive Plan and "will become 100% vested as of the date of issuance," per the filing. Following the grant, Ms. Simpson directly beneficially owns 20,000 shares/options reported on this Form 4.

Positive

• Director grant disclosed: The filing clearly reports a director equity award, supporting transparency.
• Immediate vesting: The option "will become 100% vested as of the date of issuance," giving the director full ownership rights upon grant.

Negative

• Potential dilution: Grant of 20,000 options increases potential outstanding shares if exercised (outstanding share count not provided).
• No rationale disclosed: The filing does not state the business or performance reason for immediate 100% vesting.

Insights

Financial Analyst

TL;DR: A routine director option grant of 20,000 shares at $6.41 that vests immediately; modestly dilutive but common for compensation.

The filing documents a standard equity compensation action: a director received an option to acquire 20,000 shares at $6.41 under the 2025 Equity Incentive Plan. Immediate 100% vesting aligns the director’s economic interests with shareholders without future service requirements. The grant size appears modest in absolute terms; materiality depends on the company's outstanding share count (not provided). No cash proceeds or derivative conversions were reported beyond the option grant.

Corporate Governance Expert

TL;DR: Immediate vesting is notable for governance review; disclosure is straightforward and compliant with Section 16 reporting.

The Form 4 properly discloses the director’s award and indicates it was granted under the company’s 2025 Equity Incentive Plan with immediate vesting. From a governance perspective, immediate 100% vesting removes a future service-based retention feature and may warrant board documentation explaining the rationale. The filing is signed and dated, meeting procedural requirements.

Insider Trade Summary

Net Buyer: 20,000 shares

Net Buy 1 txn

Insider Simpson Brenda Baird

Role Director

Bought 20,000 shs ($128K)

Type	Security	Shares	Price	Value
Purchase	Option (right to buy)	20,000	$6.41	$128K

Holdings After Transaction: Option (right to buy) — 20,000 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Brenda Baird Simpson report on Form 4 for STSSW?

She reported a grant of an option to purchase 20,000 shares at an exercise price of $6.41 on 08/22/2025, and the option is 100% vested at issuance.

When was the transaction dated on the Form 4 for STSSW?

The transaction date reported is 08/22/2025.

Under which plan was the STSSW option granted?

The option was granted pursuant to the company's 2025 Equity Incentive Plan.

How many shares does the director beneficially own after the reported transaction?

The Form 4 reports 20,000 shares/options beneficially owned following the transaction.

Does the Form 4 indicate any indirect ownership or joint filing?

The filing indicates direct ownership and that the form was filed by one reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/26/2025 - 09:24 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simpson Brenda Baird

(Last) (First) (Middle)

C/O SHARPS TECHNOLOGY, INC.

105 MAXESS ROAD, STE. 124

(Street)

MELVILLE NY 11747

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sharps Technology Inc. [ STSS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/22/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Option (right to buy)	08/22/2025		P		20,000	A	$6.41	20,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Granted pursuant to the Company's 2025 Equity Incentive Plan. The option will become 100% vested as of the date of issuance.

	/s/ Brenda Simpson	08/26/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.